Featured News Defence’s Successful Results on Its AccuTOX Anti-Cancer ARM Vaccine Creates a Potent Second-Generation Anti-Cancer ARM-002 Vaccine March 26, 2024
Featured News Defence Therapeutics Awarded Broad U.S. Patent Covering Its Pioneering Cancer-Killing AccuTOX(R) Technology March 4, 2024
Investing News Moderna Stock Declines Amidst Concerns Over RSV Vaccine Efficacy Drop February 9, 2024
Investing News Amgen Reports 15% Rise in Quarterly Profit Following Horizon Deal Boost February 6, 2024